1-6 of 6
Donald Edward
Close
Sort by
Journal Articles

Clinical Outcomes of Venetoclax Therapy in Patients with Relapsed/Refractory (r/r) Non Hodgkin Lymphomas (NHL)

Mitchell E. Hughes, PharmD, Daniel J. Landsburg, MD, Daniel J Rubin, PharmD, Stephen J. Schuster, MD, Jakub Svoboda, MD, Donald Edward Tsai, MD PhD, Kyle Robinson, MD, Saar I. Gill, MDPhD, Anthony R. Mato, MDMSCE, James Nathan Gerson, MD, Danielle Land, CRNP, Brenda Shelly, CRNP, Alicia McLeish, CRNP, Allison Rago, CRNP, Jennifer Gill, CRNP, Kristy Walsh, BS, Tanya Latorre, RN, Jessica K. Altman, MD, Colleen Timlin, PharmD, Donna Capozzi, PharmD, BCOP, Sunita Dwivedy Nasta, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1706.
https://doi.org/10.1182/blood-2018-99-111194
Published: 2018
Journal Articles

Efficacy and Safety of ATA129, Partially Matched Allogeneic Third-Party Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes in a Multicenter Study for Post-Transplant Lymphoproliferative Disorder

Susan Prockop, MD, Ai Li, PhD, Robert A Baiocchi, MD PhD, Nancy Bunin, MD, Kris Michael Mahadeo, MD, Eneida R. Nemecek, MD, Sarah Nikiforow, MD PhD, Ran Reshef, MD, Donald Edward Tsai, MD PhD, Willis H. Navarro, MD, Richard J. O'Reilly, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4520.
https://doi.org/10.1182/blood.V130.Suppl_1.4520.4520
Published: 2017
Journal Articles

The Changing Face of Adult Posttransplant Lymphoproliferative Disorder: Dramatic Changes in Histology between 1999-2013

Donald Edward Tsai, MD PhD, Scott Huntington, MDMPH, Ran Reshef, MDMSc, Abraham Shaked, MD, Roy Bloom, MD, Vivek Ahya, Lee Goldberg, MD, Albert Chung, Fotini Debonera, Stephen J. Schuster, MD, Stephen Joseph Bagley, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1574.
https://doi.org/10.1182/blood.V130.Suppl_1.1574.1574
Published: 2017
Journal Articles

Clinical Outcomes of Anti PD-1 Immunotherapy in Patients with Relapsed/Refractory Non Hodgkin Lymphomas

Mitchell E. Hughes, PharmD, BCPS, BCOP, Christopher Jensen, MD, Jakub Svoboda, MD, Lauren Elizabeth Strelec, BA, Matthew R. Youngman, BS, Stephen J. Schuster, MD, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Donald Edward Tsai, MD PhD, David Michael Mintzer, MD, Jennifer Gill, NP, MSN, Colleen Dorsey, BSN, Kaitlin Kennard, RN, BSN, Elizabeth T Chatburn, BS, Joanna Rhodes, MD, Krista Isaac, DO, MS, Kristy Walsh, BS, Tanya Latorre, BSN, RN, Kaley Piersanti, BS, Evan Bannister, BS, Colleen Timlin, PharmD, BCOP, Donna Capozzi, PharmD, BCOP, Anthony R. Mato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1575.
https://doi.org/10.1182/blood.V130.Suppl_1.1575.1575
Published: 2017
Journal Articles

Long Term Outcomes of Rituximab, Temozolamide, and High-Dose Methotrexate for Lymphoma Involving the Central Nervous System

Sarah Jordan Nagle, MD, Nirav N. Shah, MD, Alex Ganetsky, PharmD, BCOP, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Anthony Mato, MD, Stephen J. Schuster, MD, Donald Edward Tsai, MD PhD, Jakub Svoboda, MD
Journal: Blood
Blood (2015) 126 (23): 2701.
https://doi.org/10.1182/blood.V126.23.2701.2701
Published: 2015
Journal Articles

The Effect of Neutropenia on Myeloid Growth and the Stem Cell in an In Vivo Culture System

W. S. Tyler, M.D., Eero Niskanen, M.D., Frederick Stohlman, Jr., M.D., Jane Keane, Donald Edward
Journal: Blood
Blood (1972) 40 (5): 634–645.
https://doi.org/10.1182/blood.V40.5.634.634
Published: 1972